Federal Court Restores Full Indirect Costs for Research Grants—What This Means for You
March 6, 2026 · 3 min read
Claire Cummings
Hook
A major victory for U.S. research institutions: The U.S. Court of Appeals for the First Circuit has struck down the contentious 15% indirect cost cap on NIH and NSF research grants. This landmark decision prevents immediate implementation of restrictions that would have slashed overhead reimbursements for universities, labs, and nonprofit research centers. Stakeholders, long alarmed by potential cuts, now see a critical window of financial relief for their research operations.
Federal agencies, including the National Institutes of Health (NIH) and the National Science Foundation (NSF), had started enforcing the cap after directives from the Trump administration as part of a broader cost-reduction push. The court’s ruling, citing case 164 F.4th 1, 9 (1st Cir. 2026), immediately restores access to previously negotiated indirect cost rates—often well above 15%—across the research sector.
Context
The indirect cost cap was first proposed as an efficiency measure in early 2026, targeting reductions in the federal outlay for administrative, facilities, and compliance costs. The Trump administration made these restrictions central to its "aggressive agenda"[1] to curb federal research and defense spending. The NSF rolled out the cap earlier this year, drawing rapid pushback from universities and research advocacy groups. The NIH followed suit, impacting a wide swath of biomedical research programs.[3]
These caps soon faced legal challenges. Critics argued that arbitrary limits undermined the capacity of research institutions to maintain secure facilities, support compliance, and cover operational necessities. For many universities, indirect costs comprise essential reimbursement for services ranging from safety oversight to IT infrastructure—functions that underpin world-leading research but are seldom covered by direct grant dollars. Most research-intensive institutions have negotiated indirect rates with federal agencies, often in the range of 30–60%.[2]
In striking down the cap, the First Circuit court referenced recent Supreme Court signals (notably Justice Barrett’s concurrence in a related funding case) emphasizing that executive branch agencies cannot unilaterally override statutes or negotiated agreements with sweeping administrative orders.[2]
Impact
For Universities and Research Institutions
The ruling brings immediate fiscal relief. Restoring the previously negotiated higher indirect cost rates means universities and independent labs will not be forced to subsidize core operational support out of non-federal funds. For those that were bracing for imminent budget shortfalls, this means program stability and preserved research jobs.
For Researchers
While most researchers do not deal directly with the indirect cost rate, its reduction could have led to hiring freezes, loss of support staff, slowed projects, and reduced access to shared facilities. With the cap struck down, the risk of layoffs, deferred maintenance, or service cutbacks is temporarily averted.
For Small Research Nonprofits
Smaller nonprofits, which often operate on lean administrative budgets, would have struggled disproportionately under the cap. Indirect reimbursement is key to keeping grant-funded programs sustainable at scale, particularly as compliance and reporting burdens grow.[3]
Action: What Should You Do Now?
- Communicate with your grants office: Research administrators should confirm that proposals submitted to NIH, NSF, and other federal funders can resume using institutionally negotiated indirect cost rates.
- Update application budgets: If you are preparing new proposals, revert to your full negotiated rate for indirect costs unless agency guidance says otherwise. Draft budgets that accurately reflect your institution’s infrastructure needs.
- Monitor agency communications: The Court’s decision is subject to appeal and agencies may issue new compliance notices. Stay alert for official updates from NIH, NSF, and your institution's central research office.
- Document expenditures and compliance: Heightened scrutiny on federally funded entities—including DOJ fraud probes—means strong financial controls and clear reporting are more important than ever.[3]
Outlook: What’s Next?
While this court ruling is a clear, if provisional, win for the research community, its long-term impact remains in flux. The administration has signaled it may seek Supreme Court review or identify new regulatory avenues to limit overhead reimbursement. Grant seekers should expect the funding landscape—and the regulatory environment—to remain dynamic through the 2026 fiscal year. Watch for additional legal developments and any efforts by agencies to revise or reframe indirect cost policies.
Granted AI continuously monitors federal funding policy changes, helping you stay ahead on compliance and institutional strategy.
Sources:
- [1] Federal appeals decision context as cited
- [2] 164 F.4th 1, 9 (1st Cir. 2026); Supreme Court analysis Feb 26, 2026
- [3] NSF, NIH, and DOJ policy updates as referenced
- [5][6] Broader federal funding and tariff legal developments